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Oocyte factors not only drive somatic cell nuclear
transfer reprogramming but also augment the
efficiency and quality of induced pluripotent stem
cell (iPSC) reprogramming. Here, we show that the
oocyte-enriched factors Tcl1 and Tcl1b1 significantly
enhance reprogramming efficiency. Clonal analysis
of pluripotency biomarkers further show that the
Tcl1 oocyte factors improve the quality of reprogram-
ming. Mechanistically, we find that the enhancement
effect of Tcl1b1 depends on Akt, one of its putative
targets. In contrast, Tcl1 suppresses the mitochon-
drial polynucleotide phosphorylase (PnPase) to
promote reprogramming. Knockdownof PnPase res-
cues the inhibitory effect from Tcl1 knockdown dur-
ing reprogramming,whereasPnPaseoverexpression
abrogates the enhancement from Tcl1 overexpres-
sion. We further demonstrate that Tcl1 suppresses
PnPase’s mitochondrial localization to inhibit mito-
chondrial biogenesis and oxidation phosphorylation,
thus remodeling the metabolome. Hence, we identi-
fied the Tcl1-PnPase pathway as a critical mitochon-
drial switch during reprogramming.INTRODUCTION
Somatic cell nuclear transfer (SCNT) was the first nuclear reprog-
ramming method to be developed. In this method, a somatic
nucleus is rapidly reprogrammed by oocyte cytosolic factors to
gain pluripotency in a deterministic manner (Brambrink et al.,
2006). The cells generated from SCNT are bona fide pluripotent
stem cells, more similar to embryonic stem cells (ESCs) derived
from the fertilization of oocytes by spermatozoa than regular
induced pluripotent stem cells (iPSCs) (Stadtfeld and Hoched-
linger, 2010). However, while SCNT is conceptually straightfor-
ward, its application has been hindered by logistical difficulties
and ethical controversies, especially in humans. The advent of
transcription-factor-mediated iPSC reprogramming (Takahashi1080 Cell Reports 12, 1080–1088, August 18, 2015 ª2015 The Authoand Yamanaka, 2006) represented a significant step toward
generating patient-specific stem cells that can be used for
autologous cell replacement therapy and establishment of dis-
ease models. Compared to SCNT, this method is technically
simple and free of logistical constraints and ethical concerns
with human blastocyst destruction. Furthermore, it has revealed
important insights into the molecular mechanisms of reprogram-
ming and pluripotency.
Its only drawback is that it is less efficient at establishing com-
plete, bona fide pluripotency than SCNT (Le et al., 2014). There-
fore, it is conceivable that some oocyte cytosolic factors might
work synergistically with theOct4, Sox2, Klf4, and c-Myc nuclear
transcription factors to enhance iPSC reprogramming. However,
while many transcription factors have been shown to enhance
the generation of iPSCs, the majority of oocyte factors remain
poorly investigated.
Themammalian oocyte-enriched T-cell leukemia (Tcl1) protein
family consists of cytosolic, non-enzymatic proteins that are
known to bind the Akt kinase, among other targets (Laine
et al., 2000). Here, we show that Tcl1 and its closely related ho-
molog Tcl1b1 significantly boost the somatic reprogramming of
fibroblasts. Tcl1b1 promotes Akt activation to promote reprog-
ramming, whereas Tcl1 suppresses mitochondrial biogenesis
via PnPase to remodel the metabolome, thereby providing the
cytoplasmic milieu to enhance somatic reprogramming.RESULTS
Oocyte Tcl1 and Tcl1b1 Enhance Reprogramming of
Fibroblasts
We screened 20 oocyte-enriched genes, selected based on
their abundance in ESCs and oocytes (Wang et al., 2010b; Zhang
et al., 2009), by testing their effects on iPSC reprogramming of
mouse fibroblasts using retroviral Oct4, Sox2, and Klf4 (OSK;
Figures S1A and S1B). Out of the 20 oocyte-enriched genes,
only Tcl1 and Tcl1b1 significantly increased the number of
alkaline phosphatase (AP)-positive iPSC colonies (Figure 1A).
Endogenous Tcl1 expression is similar toNanog in that it is highly
upregulated only at the late stage of iPSC reprogramming, when
cells begin to acquire pluripotency (Figure 1B), whereas endog-
enous Tcl1b1 is undetectable throughout iPSC reprogramming.rs
Figure 1. Overexpression of Tcl1 and Tcl1b1 Enhance Somatic Reprogramming
(A) Fold change in AP-positive colonies after OSK-mediated reprogramming ofWTMEFs in amini-screen against oocyte-enriched genes, relative to empty vector
(EV) control.
(B) Gene expression of endogenous Nanog and Tcl1 during the time course of iPSC reprogramming of MEFs.
(C and D) Gene expression of (C) Tcl1 and (D) Tcl1b1 in the ovary, two ESCs, and two MEF lines.
(E) Fold change in Oct4-GFP+ colonies after Tcl1 and Tcl1b1 overexpression during OSK reprogramming of WT MEFs.
(F) Percentage of AP+ colonies that are Oct4-GFP+ after Tcl1 and Tcl1b1 overexpression during OSK reprogramming of WT MEFs.
(legend continued on next page)
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Furthermore, Tcl1 is expressed highly in both mouse oocytes
and ESCs (Figure 1C), whereas Tcl1b1 is expressed only in
oocytes (Figure 1D), consistent with previous findings (Hallas
et al., 1999). These data support their candidacy as oocyte
reprogramming factors.
To validate our initial screen results, we repeated Tcl1 and
Tcl1b1 overexpression during reprogramming of Oct4-GFP
mouse embryonic fibroblasts (MEFs) and found that both
Tcl1 factors could significantly increase Oct4-GFP+ colonies
(Figure 1E). Tcl1 and Tcl1b1 overexpression also significantly
increased the percentage ofOct4-GFP+ colonies within AP+ col-
onies (Figure 1F). This enhancement was independent of c-Myc
overexpression (Figure 1G) and p53 deletion (Figure S1C).
Conversely, somatic reprogramming efficiency was signifi-
cantly impaired by the knockdown of endogenous Tcl1 (Fig-
ure S1D) during iPSC reprogramming of either wild-type (WT)
or p53/ MEFs (Figures 1H–1J), thus highlighting its necessity
in somatic reprogramming. Taken together, these observations
suggest that the Tcl1 oocyte factors represent a distinct pathway
critical to reprogramming.
Oocyte Tcl1 and Tcl1b1 Enhance Pluripotency
Biomarkers after iPSC Derivation
Recent studies have suggested that other biomarkers, besides
Oct4-GFP fluorescence, can support the assessment of
bona fide iPSC reprogramming efficiency (Buganim et al.,
2012; Golipour et al., 2012). Therefore, we used a single-clone
profiling assay with nanofluidic chips to profile Tbx3, Nanog,
and the imprinted Dlk1-Dio3 gene cluster as biomarkers for
iPSC quality (Figure S2A), as these biomarkers had been shown
to predict bona fide pluripotency and differentiation potency
(Han et al., 2010; Niwa et al., 2009; Silva et al., 2009; Stadtfeld
and Hochedlinger, 2010). Our analysis revealed that Nanog,
Tbx3, Gtl-2, and Rian were upregulated to pluripotent ESC-
like levels in Tcl1- and Tcl1b1-expressing clones, in contrast
to OSK-only or partially reprogrammed iPSCs (Figures S2B–
S2E), whereas Dlk-1, which is imprinted and anti-correlated
with pluripotency, was downregulated to ESC-like levels in
Tcl1- and Tcl1b1-expressing clones (Figure S2F). In total, either
Tcl1 or Tcl1b1 overexpression could enhance reprogramming
to the ESC-like state (Figure S2G) with 50% efficiency among
Oct4-GFP+ colonies, whereas OSK-only could produce ESC-
like colonies with only 10% efficiency (Figure S2H). This further
supports our findings that Tcl1 and Tcl1b1 enhance iPSC
reprogramming.
Tcl1b1 Enhances Somatic Reprogramming by
Increasing Akt Activity
Next, we investigated the molecular mechanism for Tcl1- and
Tcl1b1-mediated enhancement of somatic reprogramming.
Since both Tcl1 and Tcl1b1 are known Akt1/2 cofactors (Laine(G) Fold change in AP+ colonies after Tet-inducible Tcl1 and Tcl1b1 overexpress
(H and I) Fold change in AP+ colonies after Tcl1 and Tcl1b1 shRNA knockdown
scrambled shRNA and shOct4.
(J) Images of AP-stained colonies quantified in (H).
All data are shown as themean ± SEM of three biological replicates. *p < 0.05; **p
S1 and S2.
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Although Akt1 can stimulate heterokaryon and iPSC reprog-
ramming, Akt’s role in SCNT reprogramming had remained un-
clear (Nakamura et al., 2008; Zhu et al., 2010). We observed a
gradual increase in phospho-Akt during iPSC reprogramming
by OSK factors (Figure 2A), and Akt was predominantly phos-
phorylated in ESCs relative to MEFs (Figure 2B). The pro-reprog-
ramming role of Akt was confirmed when ectopic Akt1 increased
reprogramming efficiency (Figure S3A), whereas inhibition of
endogenous Akt activity suppressed iPSC reprogramming (Fig-
ure S3B).Whenwe compared reprogramming usingOSK factors
alone, or OSK factors with either Tcl1 or Tcl1b1 overexpression,
we found that only ectopic Tcl1b1 increased Akt phosphoryla-
tion far above the level achieved by OSK factors alone (Fig-
ure 2C). This suggests that only Tcl1b1, but not Tcl1, significantly
enhances Akt activation.
To test whether Tcl1 and Tcl1b1 act through Akt activation
to promote iPSC reprogramming, we sought to verify whether
pharmacological inhibition of Akt1/2 might specifically abrogate
Tcl1’s and Tcl1b1’s enhancement of iPSC reprogramming.
Although Akt1/2 inhibition abrogated Tcl1b1’s enhancement
of iPSC reprogramming (Figure 2D), Akt1/2 inhibition failed to
abrogate the 3-fold enhancement promoted by Tcl1 (Figure 2E).
A different Akt1/2 inhibitor yielded similar results (Figure S3C).
On the other hand, co-overexpression of both Tcl1 and Tcl1b1
together synergistically increased reprogramming efficiency
more than expected (Figure 2F), implying that Tcl1’s enhance-
ment mechanism does not completely overlap with that of
Tcl1b1 and that another mechanistic target besides Akt exists
downstream of Tcl1 for reprogramming (Figure 2G).
Tcl1 Promotes Reprogramming by Suppressing
Mitochondrial PnPase
To identify this other mechanistic target of Tcl1 in reprogram-
ming, we performed co-immunoprecipitation (coIP) experiments
in MEFs expressing hemagglutinin (HA)-tagged Tcl1 (HA-Tcl1),
with and without the OSK reprogramming factors. We readily
identified endogenous Pnpt1 as Tcl1’s main binding partner (Fig-
ure 3A). Pnpt1 encodes mitochondrial polynucleotide phosphor-
ylase (PnPase), an RNA-binding protein that plays an important
role in RNA import and processing in mitochondria and, thus,
mitochondrial homeostasis (Chen et al., 2006; Wang et al.,
2010a). When we overexpressed Tcl1, the mitochondrial fraction
of endogenous PnPase was significantly reduced but not the
total pool of PnPase (Figures 3B and 3C). This suggested that
Tcl1 suppressed the mitochondrial localization—and, thus, the
mitochondrial activity—of PnPase.
Furthermore, we discovered that overexpression of Pnpt1
(Figure S4A) significantly suppressed somatic reprogramming
by 60% (Figure 3D), whereas knockdown of the Pnpt1 gene
with two independent small hairpin RNAs (shRNAs) (Figure S4B)ion during OSK + c-Myc reprogramming of MEFs.
during OSK reprogramming of (H) WT MEFs and (I) p53/ MEFs, relative to
< 0.01; ***p < 0.001; n.s., not significant. See also Figures S1 and S2 and Tables
rs
Figure 2. Tcl1b1 Promotes Akt Phosphorylation to Enhance iPSC Reprogramming
(A) Abundance of phospho-Akt (Ser473) protein during the time course of iPSC reprogramming of WT MEFs.
(B) Abundance of phospho-Akt (Ser473) protein and densitometric quantification of phospho-Akt relative to total Akt (pAkt/tAkt) in mouse ESCs and MEFs.
GAPDH served as the total protein loading control.
(C) Abundance of phospho-Akt (Ser473) protein after Tcl1 and Tcl1b1 overexpression during OSK-mediated reprogramming of WT MEFs.
(D and E) Fold change in Oct4-GFP+ colonies after (D) Tcl1b1 and (E) Tcl1 overexpression during OSK-mediated reprogramming of WT MEFs, with or without
Akt1/2 inhibitor (Akt1/2i).
(F) Fold change in Oct4-GFP+ colonies after double co-overexpression of Tcl1 and Tcl1b1 during OSK-mediated reprogramming of WT MEFs.
(G) Diagram model depicting how Tcl1 and Tcl1b1-Akt regulate somatic reprogramming.
All data are shown as the mean ± SEM of at least three biological replicates. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S3.
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Figure 3. Tcl1 Suppresses Mitochondrial PnPase to Enhance iPSC Reprogramming
(A) Western blots of coIPs (IP) between ectopic HA-Tcl1 and endogenous PnPase, immunoblotted (IB) with anti-HA or anti-PnPase. Tim13a/b is a mitochondrial
inner membrane protein and served as a negative control. Three experiments were performed with similar results. IgG, immunoglobulin G.
(B) PnPase protein in mitochondrial fraction (Mito) and total protein (Total) pools. COX IV served as the mitochondrial loading control, while GAPDH served as the
total protein loading control. EV, empty vector.
(C) Densitometric quantification of mitochondrial PnPase protein, relative to mitochondrial COX IV loading control. Three biological replicates were quantified.
(D) Fold change in Oct4-GFP+ colonies after Pnpt1 overexpression during OSK-mediated reprogramming of WT MEFs.
(E) Fold change in Oct4-GFP+ colonies after Pnpt1 shRNA knockdown during OSK reprogramming of WT MEFs.
(legend continued on next page)
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significantly enhanced iPSC reprogramming by 4-fold (Fig-
ures 3E and 3F). This enhancement was similar in magnitude to
p53 knockdown (Figure S4C), but it was even further enhanced
to 12-fold by p53 deletion (Figure S4D), suggesting that
Pnpt1 depletion also works independently of p53 depletion.
Thus, mitochondrial PnPase does inhibit iPSC reprogramming,
independently of the p53 pathway and its effects on cellular pro-
liferation and apoptosis.
To validate whether Pnpt1 functions downstream of Tcl1
during reprogramming, we performed genetic epistasis ex-
periments. We found that Pnpt1 knockdown fully rescued the
inhibitory effect of Tcl1 knockdown during reprogramming (Fig-
ure 3G). On the other hand, Pnpt1 overexpression fully abro-
gated the enhancement effect of Tcl1 during reprogramming
(Figure 3H). These data prove that mitochondrial Pnpt1 functions
downstream of Tcl1 in reprogramming (Figure 3I).
Tcl1-PnPase Pathway Reprograms the Cellular
Metabolome
While somatic cells depend mostly on mitochondrial oxidative
phosphorylation (OxPhos), pluripotent stem cells possess imma-
ture mitochondria and preferentially use glycolysis as their major
source of energy (Prigione et al., 2010; Folmes et al., 2011).
Although this preference has been well characterized in ESCs,
the pluripotency or oocyte factors responsible for this metabolic
switch during somatic reprogramming had remained incom-
pletely resolved. To test whether the Tcl1-Pnpt1 switch regulates
somatic reprogramming by regulating mitochondrial homeosta-
sis, we first examined the effects of Tcl1-Pnpt1 on mtDNA levels
as an indicator of mitochondrial replication and biogenesis.
Pnpt1-mediated import of nucleus-encoded RNAs—including
MRP and RNase P RNAs, tRNAs, and 5S rRNA—is thought to
be essential for mtDNA replication and gene expression (Wang
et al., 2010a). Interestingly, we found that Tcl1 suppressed
mtDNA by 30%, whereas Pnpt1 increased it by 50% (Figure 4A).
Moreover, Pnpt1 overexpression overwrote the effects of Tcl1
overexpression (Figure 4A), proving that it lies downstream of
Tcl1 in regulating mitochondrial biogenesis.
To understand the roles of mitochondrial Pnpt1 and Tcl1
in regulating cellular metabolism, we profiled the metabolomes
of WT MEFs overexpressing either Tcl1 or Pnpt1, using a
liquid chromatography-tandem mass spectrometry (LC-MS/
MS) platform. We observed that Tcl1 and Pnpt1 overexpression
transformed significant segments of themetabolome in opposite
directions, relative to the empty vector control (Figure 4B). In the
glycolysis pathway, Tcl1 significantly increased fructose-1,6-bi-
sphosphate (F-1,6-BP), suggesting higher phosphofructoki-
nase (PFK) flux than the control, whereas Pnpt1 significantly
decreased F-1,6-BP, suggesting lower PFK flux than the control
(Figure 4C). PFK is the major rate-limiting irreversible step in
glycolysis. Thus, Tcl1 increased input flux into glycolysis,
whereas Pnpt1 decreased input flux into glycolysis, which is(F) Images of AP-stained colonies after Pnpt1 shRNA knockdown during OSK re
(G and H) Log2 (fold change) in Oct4-GFP
+ colonies after (G) double shRNA kn
programming of WT MEFs. Fold changes were plotted in log2 scale to capture b
(I) Diagram model depicting how Tcl1-Pnpt1 and Tcl1b1-Akt regulate somatic re
All data are shown as the mean ± SEM of at least three biological replicates. *p
Cellalso evident from the significantly lower levels of glycolytic inter-
mediates from G3P to PEP (Figure 4C). At the final irreversible
step of pyruvate kinase (PK) in glycolysis, which controls the
glycolytic outflows, Tcl1 and Pnpt1 again show opposite trends.
Tcl1 significantly increased phosphoenolpyruvate (PEP) and
decreased pyruvate, whereas Pnpt1 caused opposite changes
(Figure 4C), suggesting that Tcl1 decreased PK flux to promote
the accumulation of glycolytic intermediates for growth, whereas
Pnpt1 increased PK flux to feed pyruvate into mitochondrial
OxPhos. These are supported by observations that Tcl1
increased the glycolysis-derived D-glucono-d-lactone-6-phos-
phate (Figure 4D), which shunts into the pentose phosphate
pathway for nucleotide synthesis, whereas Pnpt1 increased
the ATP/AMP ratio (Figure 4E) and decreased the glutathione
GSH/GSSG ratio (Figure 4F), indicating that Pnpt1 promoted
mitochondrial OxPhos and ROS production.
To prove that these metabolic effects of Tc1 and Pnpt1
are relevant to reprogramming and pluripotency, we imaged
and measured the mitochondrial membrane potential (Dcm) of
ESCs and MEFs undergoing OSK reprogramming (Figure 4G).
Previous studies had shown that a high Dcm can result from a
preference for glycolysis and a lower rate of respiration, leading
to a slower dissipation of the mitochondrial membrane poten-
tial (Fantin et al., 2006; Yoshida et al., 2009). Using a live Dcm
probe, we performed flow cytometry analysis on live cells and
found that Tcl1 significantly increased the proportion of ESC-
like Dcm
HIGH cells during OSK reprogramming (Figure 4H). Simi-
larly, Pnpt1 knockdown significantly increased the proportion of
ESC-like Dcm
HIGH cells during reprogramming (Figure 4I).
To confirm these metabolic observations, we examined the
bioenergetics profiles of MEFs by measuring the mitochondrial
oxygen consumption rate (OCR) to assay respiration rates and
by measuring the extracellular acidification rate (ECAR) to assay
glycolytic rates. Relative to the scrambled control, we observed
that Pnpt1 was required for normal basal and maximal respira-
tion after Pnpt1 knockdown (Figure 4J). On the other hand,
Pnpt1 knockdown increased the basal glycolysis rate, suggest-
ing that Pnpt1 suppressed glycolysis (Figure 4J). Similarly, Tcl1
overexpression decreased basal respiration and maximal respi-
ration by 40% (Figure 4K). Furthermore Tcl1 overexpression
increased the glycolytic rate by 40%–60% (Figure 4K), similar
to Pnpt1 knockdown. Most importantly, we found that Pnpt1
overexpression could rescue not only Tcl1’s inhibition of respira-
tion (Figure 4L) but also Tcl1’s enhancement of glycolytic flux
(Figure 4M), confirming that Pnpt1 acts downstream of Tcl1 in
metabolic reprogramming.
DISCUSSION
Our results contribute to solving a long-standing mystery of how
oocyte-enriched cytosolic factors facilitate reprogramming (Gur-
don and Melton, 2008). In this study, we demonstrated thatprogramming of WT MEFs.
ockdown or (H) double co-overexpression of Tcl1 and Pnpt1 during OSK re-
oth the efficiency gains and losses adequately.
programming.
< 0.05; **p < 0.01; ***p < 0.001. See also Figure S4 and Tables S1 and S2.
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Figure 4. Tcl1-PnPase Pathway Remodels the Cellular Metabolome during Reprogramming
(A) Relative mtDNA copy number after Tcl1 and Pnpt1 overexpression in MEFs, relative to the empty vector (EV) control.
(B) Heatmap of metabolite levels, as measured by LC-MS/MS metabolomics in MEFs after overexpression of Tcl1 and Pnpt1, relative to the EV control.
(C) Percent change in glycolysis intermediate levels in MEFs after overexpression of Tcl1 and Pnpt1, relative to the EV control.
(D) Percent change in D-glucono-d-lactone-6-phosphate levels in MEFs after overexpression of Tcl1 and Pnpt1, relative to the EV control.
(E) Percent change in the ATP/AMP ratio in MEFs after overexpression of Tcl1 and Pnpt1, relative to the EV control.
(F) Percent change in the GSH/GSSG ratio in MEFs after overexpression of Tcl1 and Pnpt1, relative to the EV control.
(legend continued on next page)
1086 Cell Reports 12, 1080–1088, August 18, 2015 ª2015 The Authors
the oocyte-enriched Tcl1 and Tcl1b1 proteins enhance reprog-
ramming of iPSCs. Furthermore, we established that Tcl1b1
promotes Akt activation, whereas Tcl1 suppresses mitochon-
drial PnPase localization in order to promote reprogramming.
As shown previously, mitochondrial PnPase serves to pro-
mote mitochondrial biogenesis and homeostasis (Chen et al.,
2006; Wang et al., 2010a). This supports our observations
that the Tcl1-PnPase mechanism operates as a metabolic
switch to remodel the cellular metabolome during reprogram-
ming. Furthermore, our genetic experiments with Tcl1 and
Pnpt1 perturbation in WT versus p53/ backgrounds suggest
that the Tcl1-Pnpt1 switch regulates metabolic reprogramming
independently of effects on cellular proliferation and senes-
cence. In fact, Tcl1 is directly activated by Oct4 and Stat3 (Ma-
toba et al., 2006).
Given that we explored the mechanistic basis for the iPSC
reprogramming enhancement by the Tcl1 oocyte factors, we
initially focused on Akt since it is a well-established binding
target of Tcl1 (Laine et al., 2000). We found that Akt phosphory-
lation increased during iPSC reprogramming and that Akt
signaling was both necessary and sufficient for iPSC reprogram-
ming. While we found that both Tcl1 and Tcl1b1 enhanced Akt
activity, Tcl1b1 was a significantly more potent Akt activator.
Consistently, we found that Tcl1b1-overexpressing cells were
much more sensitive to Akt inhibition than Tcl1-overexpressing
cells during reprogramming. Previous studies had also shown
that Tcl1 only modestly increases Akt activation in lymphoma
cells (Hoyer et al., 2002). Therefore, it seems that Tcl1b1 is a
more potent Akt coactivator, activating the proliferative and
metabolic pathways downstream of Akt to boost reprogram-
ming. In fact, a previous study had shown that a small molecule
agonist of the PI3K-PDK1-Akt pathway can also boost reprog-
ramming by upregulating glycolysis (Zhu et al., 2010).
For Tcl1, which did not seem as dependent on PI3K-Akt
signaling as Tcl1b1, we found instead that the mitochondrial
RNA-binding PnPase is the relevant binding target of Tcl1 during
reprogramming. While total PnPase levels were unaffected
by Tcl1, the mitochondrial fraction of PnPase was significantly
reduced by overexpression of Tcl1, indicating that Tcl1 sup-
presses PnPase’s mitochondrial localization. Suppression of
mitochondrial PnPase by RNAi also significantly enhanced
iPSC reprogramming. Through genetic epistasis experiments,
we established that PnPase is the downstream target of Tcl1 in
remodeling the metabolome during reprogramming.
PnPase regulates RNA import and processing in the mito-
chondria, which are complex processes crucial formitochondrial
biogenesis and homeostasis (Wang et al., 2010a). Although the
multitude of RNAs that are transiently processed by PnPase
remains difficult to elucidate, PnPase-mediated import of the(G) TMRM intensity distributions of stained ESCs and MEFs, relative to unstaine
(H) Percentage of Dcm
HIGH cells after Tcl1 overexpression during OSK-mediated
(I) Percentage of Dcm
HIGH cells after shRNA knockdown of Pnpt1 relative to scram
reprogramming of WT MEFs.
(J) OCR and ECAR after Pnpt1 shRNA knockdown, relative to scrambled contro
(K) OCR and ECAR after Tcl1 overexpression, relative to empty vector control.
(L andM) Here, (L) OCR and (M) ECAR after co-overexpression of Tcl1 and Pnpt1
in log2 scale to capture both the efficiency gains and losses adequately.
All data are shown as themean ± SEMof at least three biological replicates. *p < 0
CellMRP and RNase P RNAs, 5S rRNA, and tRNAs is known to be
essential for mtDNA replication and biogenesis (Wang et al.,
2010a). Indeed, cells depleted of Pnpt1 are known to have less
mitochondrial biogenesis and activity (Wang et al., 2010a),
consistent with our observations. This is also consistent with
others’ observations of lower mitochondrial biogenesis and
activity in pluripotent stem cells (Prigione et al., 2010; Folmes
et al., 2011; Liu et al., 2013). As a regulator of mitochondrial
homeostasis, we found that Tcl1-PnPase regulates mitochon-
drial OxPhos, the ATP/AMP ratio, the redox balance, and,
thus, the glycolytic flux. In particular, Tcl1-PnPase also regulates
the increased PFK flux and decreased PK flux observed during
the glycolytic switch in iPSC reprogramming (Zhu et al., 2010;
Shyh-Chang et al., 2013a; Prigione et al., 2010). Thus, the
Tcl1-PnPase mechanism serves as a metabolic switch that is
capable of remodeling the metabolome during reprogramming.
Given this important role in regulating mitochondrial homeosta-
sis, it is unsurprising that PnPase is required for mouse embryo-
genesis, muscle, brain, and inner ear development (Wang et al.,
2010a; Vedrenne et al., 2012; von Ameln et al., 2012). Since
mitochondrial numbers and functions are also tightly regulated
in pre-fertilization oocytes and early embryonic development
(Shyh-Chang et al., 2013b), the Tcl1-PnPase switch might be
relevant not only for regulating mitochondria in iPSC reprogram-
ming but also formitochondrial replacement in aged oocytes and
during in vitro fertilization.EXPERIMENTAL PROCEDURES
Murine iPSC Reprogramming Assay and Drug Treatment
Reprogramming of primaryMEFs was performed according to previously pub-
lished protocols (Takahashi and Yamanaka, 2006).
Protein Extraction and Western Blotting
Cells were harvested and processed according to previously published proto-
cols (Shyh-Chang et al., 2013a). Immunoblot membranes were probed with
specific antibodies: GAPDH, (Santa Cruz Biotechnology, SC137179), PnPase
(Santa Cruz, SC365049), Akt (Cell Signaling Technology, #9272), phosphoAkt1
(Ser473) (Cell Signaling Technology, #4060), Tim13A/B (Santa Cruz,
SC17065), and HA (Covance MMS-101P). Antibody-protein complexes were
detected by horseradish peroxidase (HRP)-conjugated antibodies and ECL-
Plus (Amersham Biosciences).
Oxygen Consumption and Extracellular Flux Measurement
Infected MEFs were seeded onto Seahorse assay plates (pre-coated with
0.1% gelatin) at 15,000 cells per well 1 day before the assay. We replaced cul-
ture media with assay media (Seahorse Bioscience) 1 hr before data collection
using the XFe96 Seahorse analyzer. Glucose (Sigma-Aldrich; final concentra-
tion, 25 mM), oligomycin (Sigma-Aldrich; final concentration, 1 mM), FCCP
(Sigma-Aldrich; final concentration, 1 mM), and amixture of antimycin and rote-
none (Sigma-Aldrich; final concentration, 1 mM) were injected sequentiallyd cells.
reprogramming of WT MEFs.
bled control at 6 days (6 dpi) or 8 days (8 dpi) post-induction of OSK-mediated
l.
in MEFs are shown, relative to empty vector control. Fold changes were plotted
.05; **p < 0.01; ***p < 0.001; ns, not significant. See also Figure S5 and Table S1.
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during measurement for bioenergetics profile analysis. Measurements were
taken according to manufacturer’s instructions.
Targeted LC-MS/MS
LC-MS/MS was performed according to previously published protocols
(Shyh-Chang et al., 2013a).
For detailed materials and procedures, please see the Supplemental Exper-
imental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.07.032.
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